SavedAdd your journal

Journals / Dicle Tıp Dergisi / 2010 / Cilt: 37 - Sayı: 1

Lipid profile and levels of homocysteine, leptin, fibrinogen and C-reactive protein in hyperthyroid patients before and after treatment

Hipertiroid hastalarda tedavi öncesi ve sonrası lipid profili ile homosistein, leptin, fibrinojen ve C-reaktif protein düzeyleri

Emine SÜTKEN
Aysen AKALIN
Filiz ÖZDEMİR
Ömer ÇOLAK
Pages
1–7
Publication Date
2010-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Pretreatment t-hcy, TC, LDL-C, HDL-C levels and BMI of patients were significantly lower than those of the post-treatment (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The present study was carried out to deter­mine whether thyroid hormones affect lipid profile and levels of erithrocyte sedimentation rate (ESR), serum total homocysteine (t-hcy), leptin, fibrinogen, C-reactive protein (CRP in patients with hyperthyroidism.
📊
Key Findings & Data:Materials and methods: This study was carried out on 23 hyperthroid subjects (3 men / 20 women, mean age 41.8 ± 2.4 years).
💡
Conclusion & Impact:Results: Pretreatment t-hcy, TC, LDL-C, HDL-C levels and BMI of patients were significantly lower than those of the post-treatment (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hipertiroidi · homosistein · leptin

Abstract

Objectives: The present study was carried out to deter­mine whether thyroid hormones affect lipid profile and levels of erithrocyte sedimentation rate (ESR), serum total homocysteine (t-hcy), leptin, fibrinogen, C-reactive protein (CRP in patients with hyperthyroidism. Materials and methods: This study was carried out on 23 hyperthroid subjects (3 men / 20 women, mean age 41.8 ± 2.4 years). Serum levels of homocysteine, leptin, fibrinogen, CRP, total cholesterol (TC), high-density lipo­protein cholesterol (HDL-C), low-density lipoprotein cho­lesterol (LDL-C) and ESR were measured and body mass index (BMI) were calculated before and after treatment of hyperthyroidism. Results: Pretreatment t-hcy, TC, LDL-C, HDL-C levels and BMI of patients were significantly lower than those of the post-treatment (p

Özet

Amaç: Bu çalışma hipertiroidizmli hastalarda tiroid hor­monlarının lipid profilini, eritrosit sedimentasyon hızını (ESR), serum total homosistein (t-hcy), leptin, fibrinojen ve C-reaktif protein (CRP) düzeylerini etkileyip etkileme­diğini tespit etmek için tasarlanmıştır. Gereç ve yöntem: Bu çalışma yaş ortalaması 41.8±2.4 yıl arasında olan 23 hipertiroid (3 erkek/ 20 kadın) ile gerçekleştirildi. Homosistein, leptin, fibrinojen, CRP, to­tal kolesterol (TK), yüksek dansiteli lipoprotein kolesterol (HDL-K), düşük dansiteli lipoprotein kolestrol (LDL-K)\'ün serum düzeyleri ve ESR ölçüldü ve vücut kütle indeksi (BMI) tedaviden önce ve sonra hesaplandı. Bulgular: Hipertiroid hastalarının tedavi öncesi t-hcy, TC, LDL-Kolesterol, HDL-Kolesterol düzeyleri ve BMI tedavi sonrası düzeylerden daha düşüktü (tüm değişkenler için, p

🔖

Cite This Article

SÜTKEN, E., AKALIN, A., ÖZDEMİR, F., ÇOLAK, Ö. (2010). Lipid profile and levels of homocysteine, leptin, fibrinogen and C-reactive protein in hyperthyroid patients before and after treatment. Dicle Tıp Dergisi, Cilt: 37 - Sayı: 1, 1–7. https://ajindex.com/articles/485481

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Faber J, Wiinberg N, Schifter S, Mehlsen J. Haemodynamic changes following treatment of subclinical and overt hyper- thyroidism. Eur J Endocrinol 2001;145:391-396.
  2. Diekman MJ, Anghelescu N, Endert E, Bakker O, Wiersinga WM. Changes in plasma low-density lipoprotein (LDL) - and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thy- roxine, not to polymorphisms in LDL receptor or choles- terol ester transfer protein genes. J Clin Endocrinol Metab 2000;85:1857-1862.
  3. Wonn-Young L, Jung-Yul S, Eun-Jung R, Jeong-Sik P, Ki- Chul S, Sun-Woo K. Plasma CRP, Apolipoprotein A-1, Apolipoprotein B and Lp (a) levels according to thyroid function status. Arch Med Res 2004;35:540-545.
  4. Chadarevian R, Bruckert E, Giral P, Turpin G. Relationship between thyroid hormones and fibrinogen levels. Blood Coagul Fibrinolysis 1999;10:481-486. Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wi- ersinga WM. Determinants of changes in plasma homo- cysteine in hyperthyroidism and hypothyroidism. Clin En- docrinol (Oxf) 2001;54:197-204.
  5. Matsubara M, Yoshizawa T, Morioka T, Katayose S. Serum leptin and lipids in patients with thyroid dysfunction. J Ath- eroscler Thromb 2000;7:50-54.
  6. Hofbauer LC, Heufelder AE. Coagulation disorders in thy- roid diseases. Eur J Endocrinol 1997;136:1-7.
  7. Yarnell JW, Baker IA, Sweetnam PM, et al. Fibrinogen, vis- cosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell col- laborative heart disease studies. Circulation 1991;83:836- 844. Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, Teger- Nilsson AC, Wedel H. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentra- tion in a general population sample of middle aged men. BMJ 1990;10300(6725): 634-638.
  8. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atheroscle- rosis 1991;91:191-205.
  9. Takeda I, Kometani T. Emergency laboratory service in Shi- mane Prefectural Central Hospital (author’s transl) Rinsho Byori 1981;29:37-41.
  10. Thompson SG, Fechtrup C, Squire E, et al. Antithrombin III and fibrinogen as predictors of cardiac events in pa- tients with angina pectoris. Arterioscler Thromb Vasc Biol 1996;16:357-362.
  11. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, El- mer SP. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as